WallStreetZenWallStreetZen

NASDAQ: MXCT
Maxcyte Inc Stock Forecast, Predictions & Price Target

Analyst price target for MXCT

Based on 2 analysts offering 12 month price targets for Maxcyte Inc.
Min Forecast
$7.00+55.56%
Avg Forecast
$9.50+111.11%
Max Forecast
$12.00+166.67%

Should I buy or sell MXCT stock?

Based on 2 analysts offering ratings for Maxcyte Inc.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their MXCT stock forecasts and price targets.

MXCT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-11-29
lockedlocked$00.00+00.00%2023-10-05

1 of 1

Forecast return on equity

Is MXCT forecast to generate an efficient return?
Company
-9.32%
Industry
18.29%
Market
35.74%
MXCT's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is MXCT forecast to generate an efficient return on assets?
Company
-8.15%
Industry
9.47%
MXCT is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

MXCT revenue forecast

What is MXCT's revenue in the next 1 years based on estimates from 2 analysts?
Avg 1 year Forecast
$42.0M+10.26%

MXCT vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
MXCT$4.50$9.50+111.11%Strong Buy
CVRX$21.92$33.67+53.59%Strong Buy
SRDX$31.50$59.00+87.30%Buy
AXGN$10.40$12.00+15.38%Strong Buy
RCEL$17.40$20.50+17.82%Strong Buy

Maxcyte Stock Forecast FAQ

Is Maxcyte Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: MXCT) stock is to Strong Buy MXCT stock.

Out of 2 analysts, 1 (50%) are recommending MXCT as a Strong Buy, 1 (50%) are recommending MXCT as a Buy, 0 (0%) are recommending MXCT as a Hold, 0 (0%) are recommending MXCT as a Sell, and 0 (0%) are recommending MXCT as a Strong Sell.

If you're new to stock investing, here's how to buy Maxcyte stock.

What is MXCT's revenue growth forecast for 2024-2024?

(NASDAQ: MXCT) Maxcyte's forecast annual revenue growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.

Maxcyte's revenue in 2024 is $38,047,000.

In 2024, MXCT is forecast to generate $4,345,031,197 in revenue, with the lowest revenue forecast at $4,215,560,660 and the highest revenue forecast at $4,474,501,733.

What is MXCT's forecast return on assets (ROA) for 2024-2024?

(NASDAQ: MXCT) forecast ROA is -8.15%, which is lower than the forecast US Medical Devices industry average of 9.47%.

What is MXCT's Price Target?

According to 2 Wall Street analysts that have issued a 1 year MXCT price target, the average MXCT price target is $9.50, with the highest MXCT stock price forecast at $12.00 and the lowest MXCT stock price forecast at $7.00.

On average, Wall Street analysts predict that Maxcyte's share price could reach $9.50 by Nov 29, 2024. The average Maxcyte stock price prediction forecasts a potential upside of 111.11% from the current MXCT share price of $4.50.

What is MXCT's forecast return on equity (ROE) for 2024-2024?

(NASDAQ: MXCT) forecast ROE is -9.32%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.